Cantabio Pharmaceuticals Inc
OTC:CTBO
Cantabio Pharmaceuticals Inc
OTC:CTBO
Price:
1.01
USD
Market Closed
Market Cap:
$20.2k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
|
S
|
Sino United Worldwide Consolidated Ltd
OTC:SUIC
|
US |
|
D
|
Darshan Orna Ltd
BSE:539884
|
IN |
|
M
|
Mirae Asset Global REIT Co Ltd
KRX:396690
|
KR |
|
C
|
Crown Holdings Inc
LSE:0I4X
|
US |
|
Galleon Gold Corp
XTSX:GGO
|
CA |
Balance Sheet
Balance Sheet Decomposition
Cantabio Pharmaceuticals Inc
Cantabio Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Cantabio Pharmaceuticals Inc
Cantabio Pharmaceuticals Inc
Balance Sheet
Cantabio Pharmaceuticals Inc
Cantabio Pharmaceuticals Inc
Currency: USD
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+51%
|
0
-85%
|
0
-96%
|
0
+25 950%
|
0
-36%
|
0
+227%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
-58%
|
0
+3 214%
|
0
+93%
|
1
+110%
|
2
+123%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
0
N/A
|
0
-28%
|
0
N/A
|
0
-10 305%
|
0
-69%
|
1
-131%
|
2
-119%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+51%
|
0
-85%
|
0
-96%
|
0
+25 950%
|
0
-36%
|
0
+227%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
